Tigermed Investor
Tigermed is a contract research company providing whole process clinical trial services for the R&D of pharmaceuticals.Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across full lifecycle of biopharmaceutical and medical device products globally.
Headquarters:
China
Last Funding Type:
Venture - Series Unknown
Investors Number:
1
Last Funding Date:
2010-03-01
Employee Number:
5001-10000
Total Funding:
8300000 USD
Founded Date:
2004
Estimated Revenue:
$100M to $500M
Industry:
Biotechnology
Funding Status:
IPO